FLT3 inhibitors

FLT3 inhibitors are targeted drugs designed to treat certain types of blood cancer, especially acute myeloid leukemia (AML). They work by specifically blocking the FLT3 protein, a receptor involved in cell growth and division. When FLT3 has mutations, it can cause cancer cells to grow uncontrollably. By inhibiting this protein, these drugs help slow or stop the growth of cancer cells, improving treatment outcomes. FLT3 inhibitors are a significant advancement because they target the disease more precisely compared to traditional chemotherapies, potentially reducing side effects and improving patients' prognosis.